The analyzed clinical studies agree with prior results obtained from animal models indicating that the treatment with probiotic and synbiotics enhanced insulin resistance in NAFLD, measured through fasting glucose, post-prandial glucose, and/or insulin levels [51,57,59,61,73]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.